Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
Clinical trial NCT01573286 · TERMINATED
Trial details
- NCT number
- NCT01573286
- Sponsor
- Alberta Children's Hospital
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2014-08-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.